Eledon Pharmaceuticals (ELDN) Equity Ratio (2016 - 2017)
Historic Equity Ratio for Eledon Pharmaceuticals (ELDN) over the last 5 years, with Q3 2017 value amounting to 0.9.
- Eledon Pharmaceuticals' Equity Ratio rose 871.01% to 0.9 in Q3 2017 from the same period last year, while for Sep 2017 it was 0.9, marking a year-over-year increase of 871.01%. This contributed to the annual value of 2.26 for FY2016, which is 34879.57% down from last year.
- According to the latest figures from Q3 2017, Eledon Pharmaceuticals' Equity Ratio is 0.9, which was up 871.01% from 0.87 recorded in Q2 2017.
- Eledon Pharmaceuticals' Equity Ratio's 5-year high stood at 0.96 during Q4 2014, with a 5-year trough of 2.26 in Q4 2016.
- Moreover, its 5-year median value for Equity Ratio was 0.9 (2017), whereas its average is 0.49.
- Per our database at Business Quant, Eledon Pharmaceuticals' Equity Ratio skyrocketed by 15611.94% in 2014 and then crashed by 34879.57% in 2016.
- Eledon Pharmaceuticals' Equity Ratio (Quarter) stood at 1.71 in 2013, then soared by 156.12% to 0.96 in 2014, then decreased by 5.47% to 0.91 in 2015, then crashed by 348.8% to 2.26 in 2016, then surged by 139.65% to 0.9 in 2017.
- Its Equity Ratio stands at 0.9 for Q3 2017, versus 0.87 for Q2 2017 and 0.9 for Q1 2017.